The first line therapy options are detailed below (1): (1) Adults with type 2 diabetes and no relevant comorbidities Offer: modified-release metformin, and an SGLT-2 inhibitor If metformin is contraindicated or not tolerated, offer monotherapy with an SGLT-2 inhibitor (2) Adults with heart failure (with any ejection fraction, unless specified) Offer: modified-release metformin, and an SGLT-2 inhibitor If metformin is contraindicated or not tolerated, offer monotherapy with an SGLT-2 inhibitor (3) Adults with atherosclerotic cardiovascular disease Offer: modified-release metformin, and an SGLT-2 inhibitor, and subcutaneous semaglutide (Ozempic), up to 1 mg once a week, for its cardiovascular, renal and glycaemic benefits
The treatment is a needle and laser-free treatment which also works on the lymphatic system
Gen Comp Endocrinol 191, 7482, doi: 10.1016/j.ygcen.2013.06.003 (2013)
You wont find the deep coaching of Found or the structured curriculum of Calibrate, but Ivys speed and simplicity make it appealing for independent users who value control and privacy over hand-holding
